Infliximab treatment of pancreatitis complicating acute kawasaki disease

Pediatric Infectious Disease Journal

Volumn 31, Issue 10, 2012, Pages 1087-1089

  Jimenez Fernandez, Susan G ^a   Tremoulet, Adriana H ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

coronary artery aneurysms; gallbladder hydrops; intravenous immunoglobulin; tumor necrosis factor ; vasculitis

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN; INFLIXIMAB;

ABDOMINAL PAIN; ARTICLE; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PANCREATITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD;

ANTIBODIES, MONOCLONAL; CHILD; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PANCREATITIS; TREATMENT OUTCOME;

EID: 84866633092     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31826108c2     Document Type: Article

References (13)

1. Burns JC, Mason WH, Glode M P, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991;118:680-686.
2. Stoler J, Biller JA, Grand RJ. Pancreatitis in Kawasaki disease. Am J Dis Child. 1987;141:306-308.
3. Baker AL, Lu M, Minich LL, et al. Pediatric Heart Network Investigators. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr. 2009;154:592-595.e2.
4. Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immuno-globulin in children with Kawasaki disease. J Pediatr. 2008;153:117-121.
5. Burns JC, Best BM, Mejias A, et al. Infiximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008;153:833-838.
6. Triantafllidis JK, Cheracakis P, Hereti IA, et al. Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infiximab treatment. Am J Gastroenterol. 2000;95:3334-3336.
7. Amano S, Hazama F, Kubagawa H, et al. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 1980;30:681-694.
8. Brown TJ, Crawford SE, Cornwall ML, et al. CD8 T lymphocytes and mac-rophages infltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184:940-943.
9. Oruc N, Ozutemiz AO, Yukselen V, et al. Infiximab: a new therapeutic agent in acute pancreatitis? Pancreas. 2004;28:e1-e8.
10. Norman JG, Fink GW, Messina J, et al. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery. 1996;120:515-521.
11. Hughes CB, Gaber LW, Mohey el-Din AB, et al. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg. 1996;62:8-13.
12. Norman JG, Fink G W, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg. 1995;130:966-970.
13. Fefferman DS, Alsahli M, Lodhavia PJ, et al. Re: Triantafllidis et al. Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infiximab treatment. Am J Gastroenterol. 2001;96: 2510-2511.